ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

AACI Backs Year 200 Goals, Secures Pledge From NCI that New Centers Won’t Be Added At Expense of Old

July 20, 1984

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

Program Announcement In Preventative Oncology

May 21, 1982

ACOS Studies Show Shift To Less Surgery In Breast Cancer

December 15, 1978

In Brief: New Arizona Cancer Center Building Dedicated; Free Copies Of FY 1988 Bypass Budget Available

November 7, 1986